JaymeELockeMDMPH

PubMed

• 195 citations
  First clinical-grade porcine kidney xenotransplant using a human decedent model.
  Paige M Porrett, Babak J Orandi, Vineeta Kumar, Julie Houp, Douglas Anderson
  American Journal of Transplantation. 2022-04-01
• 98 citations
  Proinflammatory Events Are Associated with Significant Increases in Breadth and Strength of HLA‐Specific Antibody
  Jayme E. Locke, Andrea A. Zachary, Daniel S. Warren, Dorry L. Segev, Julie A. Houp
  American Journal of Transplantation. 2009-09-01
• 43 citations
  Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis
  John P. Donnelly, Jayme E. Locke, Paul A. MacLennan, Gerald McGwin, Roslyn B. Mannon
  Clinical Infectious Diseases. 2016-07-15

Journal Articles

• Leveraging Frailty to Mitigate Sex-Based Disparities in Access to Liver Transplant  
  Saulat S Sheikh, Jayme E Locke, JAMA Surgery
• Effects of Geographic Redistribution Policy on Access to Organ Transplant—Reply  
  Michael J Hanaway, Jayme E Locke, JAMA Surgery
• Effects of Geographic Redistribution Policy on Access to Organ Transplant—Reply  
  Michael J Hanaway, Jayme E Locke, JAMA Surgery
• Quantifying Sex-Based Disparities in Liver Allocation  
  Jayme E Locke, Kim M Olthoff, Kimberly A Forde, Nancy L Ascher, JAMA Surgery
• Can You Hear Me Now? Patient Preferences for Evaluating Kidney Transplant Centers  
  Jayme E Locke, Deirdre Sawinski, American journal of transplantation
• Population Level Outcomes and Cost‐Effectiveness of Hepatitis C Treatment Pre Versus Post Kidney Transplant  
  Deirdre Sawinski, Peter P Reese, Margaux Mustian, Jayme E Locke, American journal of transplantation
• Expand the Pool of Living Donors for Kidney Transplantation  
  Jayme Locke, MD, Journal of the American Society of Nephrology
• Eculizumab and splenectomy as salvage therapy for severe antibody mediated rejection following HLA incompatible kidney transplantation  
  Orandi B, Zachary AA, Dagher N, Bagnasco S, Garonzik-Wang J, Arendonk K, Gupta N, Lonze B, Alachkar N, Kraus E, Desai N, Locke JE, Racusen L, Segev DL, Montgomery RA, Transplantation, 8/13/2014
• To whom goes the kidney?  
  Locke JE, Liver Transplantation, 1/1/2014
• What happens to liver transplant outcomes when the uninsured become insured?  
  Glueckert LN, Redden D, Thompson M, Haque A, Gray SH, Locke JE, Eckhoff DE, Fouad M, and DuBay DA, Am J Transplant, 1/1/2013
• In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression  
  Lonze BE, Holzer HT, Knabel MK, Locke JE, DiCamillo GA, Karhadkar SS, Montgomery RA, Sun Z, Warrant DS, Cameron AM, Archives of Surgery, 1/1/2012
• Desensitization in HLA-incompatible kidney recipients and survival  
  Montgomery RA, Lonze BE, King K, Kraus E, Kucirka L, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL, New Engl J Med, 1/1/2011
• Donor-derived organ transplant transmission of coccidioidomycosis  
  Dierberg KL, Marr KA, Subramanian A, Nace H, Desai N, Locke JE, Zang S, Diaz J, Chamberlain C, Neofytos D, Clinical Infect Dis, 1/1/2011
• Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients  
  Locke JE and Singer AL, Hepatic Medicine: Evidence and Research, 1/1/2011
• Renal transplantation in HIV-positive recipients  
  Locke JE and Segev DL, Current Infectious Disease Reports, 1/1/2010
• Stem cells and the liver: clinical applications in transplantation  
  Locke JE, Shamblott MJ, Cameron AM, Advances in Surgery, 1/1/2009
• ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis  
  Stewart ZA, Locke JE, Montgomery RA, Singer AL, Cameron AM, Segev DL, Liver Transplant, 1/1/2009
• C4d deposition without histologic changes of rejection correlates with reduced scarring after 1-year in ABO-incompatible renal allografts  
  Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA, J Am Soc Nephrol, 1/1/2009
• Declining outcomes in simultaneous liver kidney transplantation in the MELD era: ineffective utilization of renal allografts  
  Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, Montgomery RA, Danovitch G, Cameron AM, Transplantation, 1/1/2008
• Desensitization protocols for crossing human leukocyte antigen and ABO incompatible barriers  
  Jordan SC, Locke JE, Montgomery RA, Current Opinion in Organ Transplantation, 1/1/2007
• Biliary Cystic Disease  
  Lipsett PA and Locke JE, Current Treatment Options in Gastroenterology, 1/1/2006
• Inflammatory pseudotumor of the liver  
  Locke JE, Choti MA, Torbenson MS, Horton KM and Molmenti EP, Journal of Hepatobiliary and Pancreatic Surgery, 1/1/2005
• Join now to see all

Abstracts/Posters

• Long-term outcomes among HIV-infected kidney transplant recipients
  Locke JE, Mehta S, Aitchison S, Peck A, Deierhoi R, Segev DL, American Society of Transplant Surgeons Winter Symposium and World Transplant Congress, 1/1/2014
• Modified frailty index is associated with 30-day mortality in liver transplant recipients
  Peck-Hoffman AL, Locke JE, Deierhoi R, DuBay D, White J, Eckhoff D, Gray S, World Transplant Congress, 1/1/2014
• Kidney transplantation in nephropathic cystinosis: outcomes in the 21st century
  Mannon RB, Reed RD, Locke JE, World Transplant Congress, 1/1/2014
• Brain death is associated with loss of TLR signaling and upregulation of proinflammatory proteins
  Chen J, Antipenko S, Deierhoi R, Locke JE, Mannon RB, World Transplant Congress, 1/1/2014
• Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients
  Locke JE, James N, Mehta S, Pappas P, Singer AL, Desai NM, Montgomery RA, Segev DL, ASTS Winter Symposium, 1/1/2013
• OPO variation in cold ischemic time of locally transplanted deceased donor kidneys
  Locke JE, Massie A, Montgomery RA, Desai NM, Segev DL, ASTS Winter Symposium, 1/1/2012
• Equivalent outcomes for NIH Study Protocol and Non-Protocol HIV-infected kidney transplant recipients
  Locke JE, Singer AL, Desai N, Montgomery RA, and Segev DL, American Transplant Congress Meeting and Am J Transplant, 1/1/2011
• Risk factors predictive of liver allograft loss among HIV positive recipients
  Locke JE, Lonze BE, Warren DS, Montgomery RA, Segev DL, American Transplant Congress Meeting and Am J Transplant, 1/1/2010
• Induction immunosuppression in crossmatch positive renal transplant recipients: results of a randomized controlled trial
  Locke JE, Simpkins CE, Leffell MS, Zachary AA, Collins V, Warren DS, Segev DL, Singer AL, Haas M, Montgomery RA, Am J. Transplant and American Transplant Congress Meeting, 1/1/2009
• Generation of humanized animal livers using stem cell transplant
  Locke JE, Sun Z, Warren DS, Sheets TP, Holzer H, Shamblott MJ, Montgomery RA, Cameron AM, 128th Annual Meeting of the American Surgical Association, 1/1/2008
• The utility of anti-complement C5 antibody for the treatment of severe AMR
  Locke JE, Zachary AA, Singer AL, Stewart AL, Segev DL, Warren DS, Montgomery RA, Am J Transplant and American Transplant Congress Meeting, 1/1/2008
• Impact of pulsatile perfusion on outcomes in donation after cardiac death kidneys: implications for expanding the donor pool
  Locke JE, Segev DS, Dominici F, Warren DS, Simpkins CE, Montgomery RA, ASTS Winter Symposium, 1/1/2007
• The effect of center volume on the long-term graft survival of pulstatile perfusion preserved kidneys
  Locke JE, Montgomery RA, Warren DS, Simpkins CE, Segev DL, American Transplant Congress Meeting and Am J Transplant, 1/1/2007
• The potential utility of splenectomy in the treatment of severe acute antibody mediated rejection
  Locke JE, Zachary A, Melancon K, Warren DS, Segev DL, Montgomery RA, ASTS Winter Symposium, 1/1/2006
• The impact of proinflammatory events on antibody levels in sensitized patients
  Locke JE, Zachary AA, Warren DS, Houp JG, Montgomery RA, Leffell MS, Am J Transplant, Transplantation, and World Transplant Congress, 1/1/2006
• Hepatic artery thrombosis after pediatric liver transplantation: identification and characterization of a novel risk factor
  Locke JE, Stewart ZA, Singer AL, Warren DS, Schwarz K, Maley WR, Montgomery RA, Cameron AM, XXII International Congress of The Transplantation Society
• Join now to see all

Lectures

• Increasing Living Kidney Donation through Development of an Incompatible Kidney Transplant Program 
  9/10/2014
• Overcoming Obstacles for the Sensitized Patient 
  6/17/2014
• What’s New in Organ Donation 
  5/15/2014
• Optimizing Living Donor Kidney Transplantation: Development of an Incompatible Program 
  5/7/2014
• Options for the Sensitized Patient: An update on the UAB Incompatible Kidney Transplant Program 
  2/14/2014
• Mix and Match Kidneys: the UAB Incompatible Kidney Transplant Program 
  10/27/2013
• Kidney Transplantation and the HIV+ ESRD Patient 
  4/25/2013
• Causes and Prevention of Sensitization 
  4/5/2013
• Organs for Sale: A debate on donor incentives 
  2/18/2010
• Novel Animal Models of Hepatitis C 
  11/1/2007
• Outcomes from Donation after Cardiac Death Kidneys: Implications for Allocation and Preservation 
  4/6/2007
• Join now to see all